TAAV

TAAV Biomanufacturing Solutions, SLU (TAAV) is a cGMP manufacturer of the enzymatic DNA starting material neDNA™ used for adeno associated virus (AAV) gene therapies. The neDNA™ technology is produced using a manufacturing process that removes significant levels of bacterial contaminants, resulting in the production of enzymatic DNA product with an improved safety profile compared to plasmid DNA for the manufacture of recombinant AAV gene therapy vectors. TAAV was founded in 2019 and became 100% wholly owned by AskBio in 2022. Company headquarters, manufacturing facilities and laboratories are located in San Sebastian, Spain.

Recent Posts